Clinical trial
Levosimendan in Acute Heart Failure Following Acute Myocardial Infarction.
NCT00324766 · Oslo University Hospital, Other · Completed
Key facts
| NCT number | NCT00324766 |
|---|---|
| Title | Levosimendan in Acute Heart Failure Following Acute Myocardial Infarction. |
| Official title | Safety and Efficacy of Levosimendan in Patients With Acute Myocardial Infarction Complicated by Symptomatic Left Ventricular Failure. |
| Lead sponsor | Oslo University Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Myocardial Infarction, Heart Failure, Cardiogenic Shock |
| Intervention type | Drug |
| Interventions | levosimendan, placebo |
| Enrollment | 61 |
| Start date | Jun 1, 2006 |
| Primary completion | Sep 1, 2011 |
| Completion | Mar 1, 2012 |
| First posted | May 11, 2006 |
| Last update posted | Jun 26, 2012 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: